Profound Average Payables vs Capex To Depreciation Analysis

PRN Stock

CAD 12.09 0.59 5.13%

Profound Medical financial indicator trend analysis is much more than just breaking down Profound Medical Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Profound Medical Corp is a good investment. Please check the relationship between Profound Medical Average Payables and its Capex To Depreciation accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Average Payables vs Capex To Depreciation

Average Payables vs Capex To Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Profound Medical Corp Average Payables account and Capex To Depreciation. At this time, the significance of the direction appears to have weak relationship.

The correlation between Profound Medical's Average Payables and Capex To Depreciation is 0.35. Overlapping area represents the amount of variation of Average Payables that can explain the historical movement of Capex To Depreciation in the same time period over historical financial statements of Profound Medical Corp, assuming nothing else is changed. The correlation between historical values of Profound Medical's Average Payables and Capex To Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Average Payables of Profound Medical Corp are associated (or correlated) with its Capex To Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Depreciation has no effect on the direction of Average Payables i.e., Profound Medical's Average Payables and Capex To Depreciation go up and down completely randomly.

Correlation Coefficient

0.35

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Most indicators from Profound Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Profound Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Profound Medical's Selling General Administrative is very stable compared to the past year. As of the 27th of June 2024, Sales General And Administrative To Revenue is likely to grow to 1.63, though Tax Provision is likely to grow to (121.6 K).

	2021	2022	2023	2024 (projected)
Interest Expense	303K	174K	770K	718.0K
Depreciation And Amortization	1.9M	4.1M	4.7M	5.0M

Interest Expense Depreciation And Amortization

Profound Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Other Liab	Net Tangible Assets	Non Current Assets Total	Long Term Debt
Total Assets		0.06	0.54	0.51	0.99	0.85	-0.97	-0.77	0.72	0.99	0.97	0.66	0.85	0.88	0.78	0.72	0.5	0.54	1.0	-0.2	0.36	0.91	0.31	0.92	0.66	-0.21
Short Long Term Debt Total	0.06		0.6	0.62	-0.09	0.39	0.08	-0.48	0.43	-0.05	0.06	0.35	0.42	0.42	0.52	0.58	0.82	0.53	0.05	0.43	0.29	0.34	0.15	-0.1	0.15	0.42
Other Current Liab	0.54	0.6		0.72	0.42	0.58	-0.44	-0.66	0.76	0.47	0.53	0.39	0.71	0.63	0.84	0.61	0.84	0.54	0.52	0.18	0.45	0.64	0.36	0.33	0.43	0.03
Total Current Liabilities	0.51	0.62	0.72		0.38	0.82	-0.38	-0.67	0.94	0.4	0.44	0.56	0.7	0.65	0.81	0.69	0.91	0.71	0.46	0.62	0.8	0.63	0.71	0.25	0.76	-0.16
Total Stockholder Equity	0.99	-0.09	0.42	0.38		0.78	-0.99	-0.69	0.61	1.0	0.97	0.62	0.78	0.82	0.68	0.63	0.35	0.45	0.99	-0.3	0.26	0.85	0.23	0.95	0.6	-0.25
Property Plant And Equipment Net	0.85	0.39	0.58	0.82	0.78		-0.76	-0.8	0.87	0.79	0.79	0.73	0.85	0.87	0.86	0.8	0.75	0.72	0.82	0.3	0.58	0.86	0.45	0.67	0.78	-0.22
Net Debt	-0.97	0.08	-0.44	-0.38	-0.99	-0.76		0.74	-0.62	-0.98	-0.98	-0.64	-0.81	-0.83	-0.69	-0.66	-0.34	-0.53	-0.98	0.34	-0.21	-0.87	-0.22	-0.97	-0.54	0.26
Retained Earnings	-0.77	-0.48	-0.66	-0.67	-0.69	-0.8	0.74		-0.76	-0.7	-0.79	-0.71	-0.98	-0.94	-0.92	-0.97	-0.73	-0.88	-0.77	0.03	-0.25	-0.92	-0.34	-0.7	-0.44	0.01
Accounts Payable	0.72	0.43	0.76	0.94	0.61	0.87	-0.62	-0.76		0.63	0.67	0.6	0.82	0.77	0.89	0.73	0.85	0.72	0.67	0.38	0.77	0.78	0.72	0.5	0.83	-0.24
Cash	0.99	-0.05	0.47	0.4	1.0	0.79	-0.98	-0.7	0.63		0.96	0.61	0.79	0.83	0.7	0.64	0.39	0.46	0.99	-0.28	0.28	0.86	0.23	0.94	0.61	-0.22
Cash And Short Term Investments	0.97	0.06	0.53	0.44	0.97	0.79	-0.98	-0.79	0.67	0.96		0.69	0.85	0.9	0.76	0.72	0.44	0.58	0.98	-0.32	0.22	0.93	0.22	0.97	0.54	-0.22
Net Receivables	0.66	0.35	0.39	0.56	0.62	0.73	-0.64	-0.71	0.6	0.61	0.69		0.71	0.75	0.61	0.66	0.54	0.66	0.67	0.03	0.32	0.75	0.42	0.66	0.34	-0.39
Common Stock Total Equity	0.85	0.42	0.71	0.7	0.78	0.85	-0.81	-0.98	0.82	0.79	0.85	0.71		0.94	0.95	0.94	0.74	0.86	0.84	-0.03	0.32	0.94	0.38	0.76	0.53	-0.08
Common Stock Shares Outstanding	0.88	0.42	0.63	0.65	0.82	0.87	-0.83	-0.94	0.77	0.83	0.9	0.75	0.94		0.87	0.91	0.7	0.73	0.88	-0.09	0.33	0.99	0.32	0.82	0.58	0.0
Other Current Assets	0.78	0.52	0.84	0.81	0.68	0.86	-0.69	-0.92	0.89	0.7	0.76	0.61	0.95	0.87		0.87	0.84	0.81	0.76	0.19	0.44	0.88	0.41	0.6	0.59	-0.11
Other Stockholder Equity	0.72	0.58	0.61	0.69	0.63	0.8	-0.66	-0.97	0.73	0.64	0.72	0.66	0.94	0.91	0.87		0.77	0.89	0.71	0.02	0.29	0.86	0.32	0.63	0.48	0.17
Total Liab	0.5	0.82	0.84	0.91	0.35	0.75	-0.34	-0.73	0.85	0.39	0.44	0.54	0.74	0.7	0.84	0.77		0.69	0.46	0.45	0.66	0.66	0.53	0.24	0.6	0.14
Property Plant And Equipment Gross	0.54	0.53	0.54	0.71	0.45	0.72	-0.53	-0.88	0.72	0.46	0.58	0.66	0.86	0.73	0.81	0.89	0.69		0.53	0.18	0.25	0.72	0.36	0.49	0.35	-0.11
Total Current Assets	1.0	0.05	0.52	0.46	0.99	0.82	-0.98	-0.77	0.67	0.99	0.98	0.67	0.84	0.88	0.76	0.71	0.46	0.53		-0.26	0.29	0.91	0.25	0.94	0.6	-0.21
Short Term Debt	-0.2	0.43	0.18	0.62	-0.3	0.3	0.34	0.03	0.38	-0.28	-0.32	0.03	-0.03	-0.09	0.19	0.02	0.45	0.18	-0.26		0.59	-0.12	0.42	-0.47	0.38	-0.2
Intangible Assets	0.36	0.29	0.45	0.8	0.26	0.58	-0.21	-0.25	0.77	0.28	0.22	0.32	0.32	0.33	0.44	0.29	0.66	0.25	0.29	0.59		0.31	0.86	0.06	0.86	-0.16
Common Stock	0.91	0.34	0.64	0.63	0.85	0.86	-0.87	-0.92	0.78	0.86	0.93	0.75	0.94	0.99	0.88	0.86	0.66	0.72	0.91	-0.12	0.31		0.32	0.86	0.57	-0.12
Other Liab	0.31	0.15	0.36	0.71	0.23	0.45	-0.22	-0.34	0.72	0.23	0.22	0.42	0.38	0.32	0.41	0.32	0.53	0.36	0.25	0.42	0.86	0.32		0.1	0.67	-0.32
Net Tangible Assets	0.92	-0.1	0.33	0.25	0.95	0.67	-0.97	-0.7	0.5	0.94	0.97	0.66	0.76	0.82	0.6	0.63	0.24	0.49	0.94	-0.47	0.06	0.86	0.1		0.42	-0.23
Non Current Assets Total	0.66	0.15	0.43	0.76	0.6	0.78	-0.54	-0.44	0.83	0.61	0.54	0.34	0.53	0.58	0.59	0.48	0.6	0.35	0.6	0.38	0.86	0.57	0.67	0.42		-0.12
Long Term Debt	-0.21	0.42	0.03	-0.16	-0.25	-0.22	0.26	0.01	-0.24	-0.22	-0.22	-0.39	-0.08	0.0	-0.11	0.17	0.14	-0.11	-0.21	-0.2	-0.16	-0.12	-0.32	-0.23	-0.12

Click cells to compare fundamentals

Profound Medical Account Relationship Matchups

Profound Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	29.9M	104.6M	86.8M	64.4M	43.9M	46.2M
Short Long Term Debt Total	10.9M	1.7M	1.4M	8.2M	9.5M	5.7M
Other Current Liab	530.0K	757K	248K	919K	1.1M	703.0K
Total Current Liabilities	8.2M	4.8M	4.2M	4.2M	6.4M	5.1M
Total Stockholder Equity	14.3M	97.4M	80.6M	52.0M	31.2M	36.2M
Property Plant And Equipment Net	2.2M	2.3M	1.9M	1.7M	1.5M	1.4M
Net Debt	(3.8M)	(82.2M)	(65.8M)	(38.3M)	(34.5M)	(36.2M)
Retained Earnings	(100.3M)	(130.0M)	(160.7M)	(189.4M)	(217.9M)	(207.0M)
Accounts Payable	3.0M	3.4M	3.2M	2.0M	3.3M	2.7M
Cash	14.7M	83.9M	67.2M	46.5M	26.2M	32.4M
Cash And Short Term Investments	14.7M	83.9M	67.2M	46.5M	53.5M	33.7M
Net Receivables	3.3M	7.4M	1.4M	6.3M	6.8M	3.6M
Common Stock Total Equity	98.4M	120.9M	130.3M	211.5M	243.3M	255.4M
Common Stock Shares Outstanding	11.1M	17.3M	20.5M	20.8M	21.4M	12.5M
Liabilities And Stockholders Equity	29.9M	104.6M	86.8M	64.4M	74.1M	46.0M
Other Current Assets	1.0M	1.1M	1.1M	1.2M	1.4M	1.5M
Other Stockholder Equity	15.0M	11.3M	17.0M	18.7M	21.5M	22.6M
Total Liab	15.6M	7.3M	6.2M	12.4M	12.7M	10.1M
Property Plant And Equipment Gross	2.9M	2.3M	1.9M	1.7M	4.8M	5.0M
Total Current Assets	22.7M	97.7M	77.1M	62.0M	41.9M	41.4M
Accumulated Other Comprehensive Income	(89.7K)	4.6M	4.7M	16.8M	19.4M	20.3M
Short Term Debt	4.1M	312K	250K	762K	685.8K	1.2M
Intangible Assets	2.4M	1.9M	1.4M	680K	490K	465.5K
Common Stock	99.7M	211.5M	219.6M	205.8M	236.7M	124.1M
Other Liab	654K	1.1M	875K	764K	878.6K	1.1M
Net Tangible Assets	9.3M	92.8M	76.5M	51.3M	59.0M	38.9M
Non Current Assets Total	7.2M	6.9M	9.7M	2.4M	2.0M	1.9M
Long Term Debt	10.6M	6.7M	0.0	6.7M	5M	5.3M
Long Term Debt Total	8.8M	1.4M	1.1M	7.5M	8.6M	5.4M
Non Current Liabilities Total	7.4M	2.4M	2.0M	8.2M	6.4M	5.5M
Capital Surpluse	19.6M	11.3M	17.0M	18.7M	21.5M	13.0M
Short Long Term Debt	4.7M	1.3M	5.1M	523K	2.1M	2.7M
Property Plant Equipment	2.2M	2.3M	1.9M	1.7M	2.0M	1.7M
Current Deferred Revenue	501.2K	358K	477K	471K	541.7K	380.5K
Inventory	3.6M	5.3M	7.4M	7.9M	7.0M	4.9M
Net Invested Capital	23.4M	97.4M	80.6M	59.2M	38.3M	53.8M
Net Working Capital	14.5M	92.9M	73.0M	57.8M	35.5M	47.3M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Profound Stock

When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:

How To Invest In Profound

Details

Is Profound Stock a good investment?

Details

What is Profound Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Profound Average Payables vs Capex To Depreciation Analysis

Average Payables vs Capex To Depreciation

Average Payables vs Capex To Depreciation Correlation Analysis

Correlation Coefficient

Average Payables

Capex To Depreciation

Profound Medical fundamental ratios Correlations

Profound Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Profound Medical fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Additional Information and Resources on Investing in Profound Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash	+ 1.0	Total Stockholder Equity
Total Stockholder Equity	+ 0.99	Total Assets
Cash	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Stockholder Equity
Total Current Assets	+ 0.99	Cash

Net Debt	- 0.99	Total Stockholder Equity
Common Stock Total Equity	- 0.98	Retained Earnings
Total Current Assets	- 0.98	Net Debt
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Other Stockholder Equity	- 0.97	Retained Earnings